DB289 ( DrugBank: - )

---

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
65	原発性免疫不全症候群	2

65. 原発性免疫不全症候群

---

臨床試験数 : 500 /  薬物数 : 614 - (DrugBank : 119) / 標的遺伝子数 : 92 - 標的パスウェイ数 : 217

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00803933 (ClinicalTrials.gov)	February 2003	4/12/2008	Trial of DB289 for the Treatment of Stage I African Trypanosomiasis	Phase II b Trial of DB289 for the Treatment of Stage I African Trypanosomiasis	African Trypanosomiasis	Drug: DB289;Drug: Pentamidine	Immtech Pharmaceuticals, Inc	Bill and Melinda Gates Foundation	Completed	15 Years	50 Years	Both	111	Phase 2	Congo
2	NCT00802594 (ClinicalTrials.gov)	August 2001	3/12/2008	A Trial of DB289 for the Treatment of Stage I African Trypanosomiasis	Phase II A Trial of DB289 for the Treatment of Stage I African Trypanosomiasis	Trypanosomiasis, African	Drug: DB289	Immtech Pharmaceuticals, Inc	Bill and Melinda Gates Foundation	Completed	16 Years	N/A	Both	30	Phase 2	Angola;Congo